🇺🇸 FDA
Company

NeuroSense

NeuroSense Therapeutics

NRSN pharma USA

Quick answer

NeuroSense is a pharma company (NRSN) headquartered in HERZLIYA, L3, USA with 6 tracked pipeline programs.

Pipeline (6)

project

Fixed dose combination Ciprofloxacin/Celecoxib

Amyotrophic Lateral Sclerosis

Phase 2 · small_molecule · completed

1 trials project

PrimeC

Alzheimer Disease

Phase 2 · small_molecule · terminated

1 trials project

PrimeC

Amyotrophic Lateral Sclerosis

Phase 2 · small_molecule · completed

1 trials project

Fixed dose combination Ciprofloxacin/Celecoxib

ALS (Amyotrophic Lateral Sclerosis)

Phase 1 · small_molecule · completed

1 trials project

PrimeC 748 mg

Pharmacokinetics

Phase 1 · small_molecule · completed

1 trials project

PrimeC-ER 748 mg

Pharmacokinetics

Phase 1 · small_molecule · completed

1 trials

Patents (2)

patent

US 12097185

Compositions comprising ciprofloxacin and celecoxib

Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10980780

Methods and compositions of anti-inflammatory drug and dicer activator for treat

Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)